By Tarini Parti

 

President Biden said his administration was working with officials at Pfizer Inc., Moderna Inc. and Johnson & Johnson to develop contingency plans for vaccines or boosters in case they are needed to combat the Omicron variant of the coronavirus.

Mr. Biden said at this time officials don't think such additional measures will be needed.

He also said he will soon release a strategy outline for how the administration plans to deal with Covid-19 this winter, adding that the plans would focus on more vaccinations, boosters and testing rather than lockdowns.

"This variant is a cause for concern, not a cause for panic," he said.

 

Write to Tarini Parti at tarini.parti@wsj.com

 

(END) Dow Jones Newswires

November 29, 2021 12:51 ET (17:51 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Moderna Charts.